[
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-1",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Definition / general",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#definitiongeneral226571",
    "clean_content": "Definition / general\n\n* Autosomal dominant disorder caused by mutations of serine protease 1 (*PRSS1*), also known as the cationic trypsinogen gene, characterized by progressive irreversible lipomatous atrophy of the pancreatic parenchyma leading to pancreatic insufficiency ([Am J Surg Pathol 2014;38:346](24525505))* Most common subtype of familial hereditary pancreatitis (80%); other gene mutations associated with chronic pancreatitis include *SPINK1, CFTR* and *CTRC** Incomplete penetrance; 40 - 93% of mutation carriers develop chronic pancreatitis* Patients may develop pancreatic intraepithelial neoplasia (PanIN) and have an increased lifetime risk of pancreatic cancer"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-2",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Essential features",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#essentialfeatures226572",
    "clean_content": "Essential features\n\n* Autosomal dominant mutation of *PRSS1* with incomplete penetrance* Recurrent episodes of acute pancreatitis that progress to chronic pancreatitis and lipomatous atrophy of the pancreas* Increased risk of pancreatic cancer"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-3",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Terminology",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#terminology226573",
    "clean_content": "Terminology\n\n* Familial pancreatitis, hereditary chronic pancreatitis, autosomal dominant hereditary pancreatitis, recurrent or relapsing acute or chronic pancreatitis"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-4",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "ICD coding",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#icdcoding226574",
    "clean_content": "ICD coding\n\n* ICD-10: [K86.1](https://www.icd10data.com/ICD10CM/Codes/K00-K95/K80-K87/K86-/K86.1) - other chronic pancreatitis"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-5",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Epidemiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#epidemiology226575",
    "clean_content": "Epidemiology\n\n* Age of onset ranges from infancy to sixth decade of life* Highest prevalence in the mid and southeastern regions of the United States, as well as parts of France, England and Germany ([Clin Gastroenterol Hepatol 2004;2:252](15017610), [Pancreatology 2001;1:439](12120221))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-6",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Pathophysiology",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#pathophysiology226576",
    "clean_content": "Pathophysiology\n\n* R122H and N29I mutations in *PRSS1* result in an increased propensity for trypsin-mediated trypsinogen activation, referred to as autoactivation, resulting in increased inappropriate intrapancreatic trypsin activity and digestion of the pancreatic parenchyma ([Clin Exp Gastroenterol 2016;9:197](27555793))* R122H mutation is a dual gain of function mutation that also prevents the autodegradation of active trypsin ([Biochem Biophys Res Commun 2000;278:286]( 11097832))* Obstruction from intraductal calculi may be responsible for lipomatous atrophy; exact mechanism unclear"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-7",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Clinical features",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#clinicalfeatures226577",
    "clean_content": "Clinical features\n\n* Recurrent episodes of acute pancreatitis, typically starting in childhood, with progression to chronic pancreatitis over time* Presentation of acute and chronic pancreatitis is clinically indistinguishable from other etiologies for pancreatitis"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-8",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#diagnosis226578",
    "clean_content": "Diagnosis\n\n* Patients should be suspected of *PRSS1* associated hereditary pancreatitis with the following: acute pancreatitis occurring in childhood; recurrent acute pancreatitis of unknown etiology; chronic pancreatitis of unknown cause (especially among individuals before age 25); a family history of recurrent acute pancreatitis and chronic pancreatitis following an autosomal dominant pattern of inheritance; and a family history of pancreatitis and pancreatic cancer* Considering the aforementioned suspected clinical findings, a diagnosis is established by the identification of a heterozygous pathologic mutation in *PRSS1** Rare cases of *PRSS1* R122H and A16V mutations have been reported in nonhereditary pancreatitis; therefore, family history prior to genetic testing is important to avoid misclassification and unnecessary testing ([Clin Genet 2001;59:189](11260229),\n      [Pancreas 2001;22:18](11138965))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-9",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Prognostic factors",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#prognosticfactors226579",
    "clean_content": "Prognostic factors\n\n* R122H mutation may be associated with a more aggressive course, with earlier onset and increased severity of disease ([Br J Surg 2000;87:170](10671922))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-10",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Case reports",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#casereports226580",
    "clean_content": "Case reports\n\n* 38 month old boy with pancreaticopleural fistula ([Pediatr Gastroenterol Hepatol Nutr 2019;22:601](31777728))* 12 year old boy with recurrent abdominal pain ([Tohoku J Exp Med 2001;195:191](11874252))* 15 year old girl with painless, progressive abdominal distention ([Postgrad Med J 1986;62:873](3809082))* 11 family members with chronic pancreatitis ([Arch Dis Child 1999;80:473](10208958))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-11",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Treatment",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#treatment226581",
    "clean_content": "Treatment\n\n* Management is the same as for sporadic disease* Total pancreatectomy may be considered in older patients due to the increased risk of cancer ([World J Gastroenterol 2003;9:1](12508340))* Relatives should undergo genetic counseling"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-12",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross description",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#grossdescription226582",
    "clean_content": "Gross description\n\n* Pediatric specimens are typically unremarkable* Adult specimens are soft and shrunken with marked atrophy and fat replacement, ductal dilatation and multiple intraductal calcifications"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-13",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Gross images",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#grossimages226583",
    "clean_content": "Gross images\n\n*Contributed by Aatur D. Singhi, M.D., Ph.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi01.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi01.jpg)\n\nGross parenchymal atrophy"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-14",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) description",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#microscopichistologicdescription226584",
    "clean_content": "Microscopic (histologic) description\n\n* Childhood (early) changes\n  + Patchy loss of acinar and ductal tissue+ Loose perilobular and interlobular fibrosis+ Relative preservation and aggregation of islets of Langerhans (resulting in a hyperplastic appearance)* Young adult (second to third decade of life) changes\n    + Progressive loss of acinar cell mass and ductal epithelium and increased fibrosis over time+ Fibrosis is increasingly intermingled with adipocytes+ Islets of Langerhans are still preserved* Older adult (fourth to sixth decade of life) changes\n      + Near complete replacement of pancreatic parenchyma by mature adipose tissue with scattered islets of Langerhans and nerves+ Primarily periductal fibrosis+ Main pancreatic duct and larger interlobular ducts are more likely to be dilated, while smaller ducts are reduced or scarred+ Amyloid deposition may be seen* Nonspecific ductal changes such as atrophy, dilatation, squamous metaplasia and intraductal calcifications* Can be associated with pancreatic intraepithelial neoplasia at any age ([Am J Surg Pathol 2014;38:346](24525505), [Dig Liver Dis 2012;44:8]( 21907651))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-15",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Microscopic (histologic) images",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#microscopichistologicimages226585",
    "clean_content": "Microscopic (histologic) images\n\n*Contributed by Aatur D. Singhi, M.D., Ph.D.*  \n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi02.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi02.jpg)\n\nEarly microscopic changes\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi03.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi03.jpg)\n\nResidual islets of Langerhans\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi04.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi04.jpg)\n\nProgressive replacement by fibrosis and fat\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi05.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi05.jpg)\n\nNear complete replacement\n\n[![Missing Image](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi06.jpg)](https://www.pathologyoutlines.com/imgau/pancreashereditarySinghi06.jpg)\n\nLow grade PanIN"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-16",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Molecular / cytogenetics description",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#molecularcytogeneticsdescription226586",
    "clean_content": "Molecular / cytogenetics description\n\n* 2 most common *PRSS1* mutations are the R122H and N29I missense mutations* > 30 mutations within *PRSS1* have been identified; other less common mutations include A16V, R122C, N29T, D22G and K23R ([Clin Gastroenterol Hepatol 2004;2:252](15017610))"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-17",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Sample pathology report",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#samplepathologyreport226587",
    "clean_content": "Sample pathology report\n\n* Pancreas, biopsy:\n  + Pancreatic parenchyma with intralobular and interlobular fibrosis (history of hereditary pancreatitis)* Pancreas, total pancreatectomy:\n    + Pancreatic parenchyma with intralobular and interlobular fibrosis, marked acinar parenchymal loss and pseudolipomatous atrophy (history of hereditary pancreatitis)+ Low grade pancreatic intraepithelial neoplasia+ Benign cystic dilation of small and large pancreatic ducts with associated reactive epithelial changes including squamous metaplasia+ Reactive bile duct mucosal changes with associated fibrosis+ 15 benign lymph nodes+ Negative for malignancy"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-18",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Differential diagnosis",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#differentialdiagnosis226588",
    "clean_content": "Differential diagnosis\n\n* [Cystic fibrosis](https://www.pathologyoutlines.com/topic/pancreascysticfibrosis.html):\n  + Autosomal recessive disorder caused by *CFTR* mutation+ Progressive pancreatitis also characterized by lipomatous pseudohypertrophy; may share a common pathophysiological mechanism+ Majority of patients present with pancreatic insufficiency in utero or early infancy* Alcoholic / obstruction associated [chronic pancreatitis](https://www.pathologyoutlines.com/topic/pancreaschronic.html):\n    + Fibrosis in *PRSS1* hereditary pancreatitis is relatively thinner and less compact ([Am J Surg Pathol 2014;38:346](24525505))* **Lipomatous pseudohypertrophy of the pancreas**:\n      + Common degenerative change in the obese and elderly+ Typically presents as a focal lesion and not as extensive as seen in *PRSS1* pancreatitis* Other conditions associated with lipomatous pseudohypertrophy include [Cushing syndrome](https://www.pathologyoutlines.com/topic/adrenalcushings.html), **steroid therapy, malnutrition, viral infection, main pancreatic duct obstruction** and **other genetic syndromes**"
  },
  {
    "id": "prss1-hereditary-pancreatitis_34003_1750166975.txt-19",
    "source_document": "prss1-hereditary-pancreatitis_34003_1750166975.txt",
    "parent": "pancreas_87",
    "parent_url": "",
    "topic": "Additional references",
    "url": "https://www.pathologyoutlines.com/topic/pancreashereditary.html#additionalreferences226589",
    "clean_content": "Additional references\n\n* [Gastroenterology 1952;21:54](14926813), [Gastroenterology 1996;110:1975](8964426)"
  }
]